ProMIS Neurosciences, Inc.
PMN
$9.75
$0.040.36%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -4,248.57% | -1,529.36% | -5,097.59% | 30.92% | 92.14% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 104.41% | 104.67% | 68.43% | -8,081.21% | -2,523.62% |
| Change in Net Operating Assets | 250.50% | 191.63% | 173.19% | 137.43% | 53.13% |
| Cash from Operations | -63.06% | -3.45% | -23.97% | -34.78% | -17.47% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | 0.00% | 46.15% | 46.15% | 46.15% |
| Cash from Investing | 0.00% | 0.00% | 46.15% | 46.15% | 46.15% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 226.27% | -27.37% | -24.41% | 50.06% | 50.06% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 228.79% | -24.86% | -20.38% | 54.33% | 54.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 845.07% | -1,135.31% | -231.47% | 1,628.06% | 802.84% |